Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Falling Comet
1563.8000 -11.10 (-0.70%)
NSE Dec 19, 2025 12:23 PM
Volume: 2,092
 

1563.80
-0.70%
ICICI Securities Limited
The poultry vaccine business faced significant headwinds in FY20 as a sharp spike in maize prices (accounting for ~50% of feed cost) hampered the vaccination drive among poultry farmers. Just when things were returning to normalcy, came the Covid disturbance. Uncertainty remains upon normalisation of chicken, egg consumption pattern to pre-Covid level. The animal health segment, on the other hand, is expected to remain strong due to tenders and strong export potential. However, fortunes in the poultry segment would continue to weigh on sentiments. We arrive at a...
Hester Biosciences has lost -35.63% in the last 1 Year
More from Hester Biosciences Ltd.
Recommended